Allenex AB: Interim Report January - June 2013  
8/29/2013 6:38:47 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Regulatory News:

Allenex AB (STO:ALNX):

For the April-June period

ยท Net sales for the quarter amounted to SEK 27.2 million (28.7). Sales were impacted by a negative currency effect of SEK 1.2 million compared to the same period last year.

Help employers find you! Check out all the jobs and post your resume.